Activating transcription factor-3 (ATF3) functions as a tumor suppressor in colon cancer and is up-regulated upon heat-shock protein 90 (Hsp90) inhibition
about
P53 mutations in colorectal cancer - molecular pathogenesis and pharmacological reactivationActivating transcription factor 3 promotes malignance of lung cancer cells in vitroHigh-amylose resistant starch increases hormones and improves structure and function of the gastrointestinal tract: a microarray study.Systems analysis of ATF3 in stress response and cancer reveals opposing effects on pro-apoptotic genes in p53 pathway.Activating transcription factor 3-mediated chemo-intervention with cancer chemokines in a noncanonical pathway under endoplasmic reticulum stressSmall molecule inhibition of cytoskeletal dynamics in melanoma tumors results in altered transcriptional expression patterns of key genes involved in tumor initiation and progression.Loss of ATF3 promotes Akt activation and prostate cancer development in a Pten knockout mouse modelThe common stress responsive transcription factor ATF3 binds genomic sites enriched with p300 and H3K27ac for transcriptional regulation.Site-specific gene expression profiling as a novel strategy for unravelling keloid disease pathobiology.STAT5b as molecular target in pancreatic cancer--inhibition of tumor growth, angiogenesis, and metastases.Detection of gene communities in multi-networks reveals cancer drivers.In Vitro Anticancer Activity of Phlorofucofuroeckol A via Upregulation of Activating Transcription Factor 3 against Human Colorectal Cancer CellsUpregulation of ATF-3 is correlated with prognosis and proliferation of laryngeal cancer by regulating Cyclin D1 expression.ASBEL-TCF3 complex is required for the tumorigenicity of colorectal cancer cells.Expression and clinical significance of activating transcription factor 3 in human breast cancer.The activating transcription factor 3 protein suppresses the oncogenic function of mutant p53 proteins.Ribosomal protein L34 promotes the proliferation, invasion and metastasis of pancreatic cancer cells.ATF3 and extracellular matrix-related genes associated with the process of chronic obstructive pulmonary.Drug-Induced HSP90 Inhibition Alleviates Pain in Monoarthritic Rats and Alters the Expression of New Putative Pain Players at the DRG.The catalytic topoisomerase II inhibitor dexrazoxane induces DNA breaks, ATF3 and the DNA damage response in cancer cells.Activating transcription factor 3 promotes colon cancer metastasis.Expression of core 3 synthase in human pancreatic cancer cells suppresses tumor growth and metastasis.3,3'-diindolylmethane induces activating transcription factor 3 (ATF3) via ATF4 in human colorectal cancer cells.An analog of withaferin A activates the MAPK and glutathione "stress" pathways and inhibits pancreatic cancer cell proliferation.Key role of ATF3 in p53-dependent DR5 induction upon DNA damage of human colon cancer cells.Canonical NF-κB signaling in hepatocytes acts as a tumor-suppressor in hepatitis B virus surface antigen-driven hepatocellular carcinoma by controlling the unfolded protein response.Overexpression of the transcription factor ATF3 with a regulatory molecular signature associates with the pathogenic development of colorectal cancer.Enhanced Therapeutic Treatment of Colorectal Cancer Using Surface-Modified Nanoporous Acupuncture NeedlesAtf3 deficiency promotes genome instability and spontaneous tumorigenesis in mice.Glucose-regulated protein 78 mediates the therapeutic efficacy of 17-DMAG in colon cancer cells.Neuropilin-1 promotes the oncogenic Tenascin-C/integrin β3 pathway and modulates chemoresistance in breast cancer cells.Serum and Adipose Tissue mRNA Levels of ATF3 and FNDC5/Irisin in Colorectal Cancer Patients With or Without Obesity
P2860
Q27021759-015E9A83-7704-4381-951B-7C951D8EBE31Q33633724-B21B9C8B-37C4-46E8-853E-9ABD4027B088Q33647780-8A089173-E679-4FB9-8E95-053DBF138BE2Q34064732-861F2BEB-8904-472E-879E-91A803CB287FQ34245091-D29A0EB8-1D95-4149-9938-2CC50AC1F838Q35533127-36B3730D-56BF-4385-97BF-1B87DD23A03CQ35768325-3027E966-F0F0-4163-ADC8-D28BE0E0AD8BQ36008822-E6FF2902-E7D5-40DF-81ED-DD7E144A11DAQ36296731-37645283-EE50-4186-B071-42485A7B581CQ36343768-01C7C666-0B1D-45A1-8F44-640E2A14D9A1Q36350132-DBE2D254-ADC9-42AE-A1FB-489D47837D72Q36847345-D7A15382-EDD7-4602-9962-A19E5BE2B432Q37228820-5FECDEC6-0E7F-4996-A07A-62B00E38D086Q37417916-EFC432E0-4F55-4FBB-8496-E23F96A797EEQ37540417-4AD94D9C-56EA-4402-A7D7-FB3886330055Q37691694-F06EAC90-2835-4230-B262-8C0B412CD5A4Q37709131-2CEB6E5B-A0F1-45F4-98E3-256D360F7D43Q38305019-494F3351-EFD1-4EFD-A602-EB6B93086469Q38760513-E3AD40A2-DC87-4DF7-8FBF-340964046726Q38927458-9D5F9E19-E4DC-4BEE-A61B-76F3F1161010Q38991694-0C6C14F1-56D1-4D6A-AE65-9F92321C61F2Q39141218-CCD215DE-A966-4529-AFE2-0200F78CE5E5Q39310806-823D1524-E7F3-45CD-9F42-A844AEF3FE30Q39442816-CE7AA2BF-A09F-4557-AFB4-B32F556BBE85Q39472164-2A34464D-2888-41FF-B084-7FD8F3BC2C4DQ40785717-171A5264-678D-443A-9A68-A9D3673694C0Q41470878-ABA40C2A-C18D-45A6-8037-01FD59B89670Q42374214-D8C60F57-07A0-478A-8129-7EAA16A66AAAQ50225374-A0D6D2DA-E124-4441-9653-581CBAC9AB82Q53636138-759DA190-235F-4F62-BEF1-D3BB769DA60DQ54979733-9B3F3BB3-4ACC-4B6C-BB95-E1DFD52912E5Q58754098-FCE700C8-A9B2-4F7C-B39E-CC87819E0ADD
P2860
Activating transcription factor-3 (ATF3) functions as a tumor suppressor in colon cancer and is up-regulated upon heat-shock protein 90 (Hsp90) inhibition
description
2010 nî lūn-bûn
@nan
2010 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Activating transcription facto ...... protein 90 (Hsp90) inhibition
@ast
Activating transcription facto ...... protein 90 (Hsp90) inhibition
@en
type
label
Activating transcription facto ...... protein 90 (Hsp90) inhibition
@ast
Activating transcription facto ...... protein 90 (Hsp90) inhibition
@en
prefLabel
Activating transcription facto ...... protein 90 (Hsp90) inhibition
@ast
Activating transcription facto ...... protein 90 (Hsp90) inhibition
@en
P2093
P2860
P356
P1433
P1476
Activating transcription facto ...... protein 90 (Hsp90) inhibition
@en
P2093
Akira Mori
Christian Moser
Christina Hackl
Claus Hellerbrand
Edward K Geissler
Hans J Schlitt
Oliver Stoeltzing
Stefan Fichtner-Feigl
Sven A Lang
Wolfgang Dietmeier
P2860
P2888
P356
10.1186/1471-2407-10-668
P407
P577
2010-12-03T00:00:00Z
P5875
P6179
1031631593